Mode
Text Size
Log in / Sign up
N/A Completed N=5,389 Randomized Prevention

Evaluation of a mHealth Intervention to Increase Adherence to Triage of Self-collected HPV+ Women (ATICA Project)

Patient Adherence
Source: ClinicalTrials.gov NCT03478397 ↗
Enrolled (actual)
5,389
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Percentage of Women With Triage Pap Smears at 120 Days After HPV Results — 314; 163 Participants

Summary

Background: Cervical cancer is one of the leading causes of cancer death among women worldwide, with more than 85% of cases occurring in low- and middle-income countries. Human papillomavirus (HPV) screening allows for self-collection with the potential to increase coverage, but still requires triage to identify which HPV+ women need diagnostic and treatment procedures. However, achieving high levels of triage adherence can be challenging, especially among socially vulnerable women. The ATICA protocol (Application of Communication and Information Technologies to Self-Collection, for its initials in Spanish), aimed at evaluating the implementation strategy and the effectiveness of a multi-component mobile health (mHealth) intervention to increase adherence to triage among women with HPV+ self-collected tests. Methods: Researchers will use an effectiveness-implementation hybrid type I trial with a mixed-methods evaluation approach. A cluster randomized trial design including 200 community health workers (CHWs) will evaluate whether the mHealth intervention increases adherence to triage among HPV+ women who self-collected at home during a CHW visit within 120 days after a positive result. The intervention includes an initial mobile phone text message (SMS) alert and subsequent reminders sent to HPV+ women. For those who do not adhere to triage within 60 days of a positive HPV test, an email and SMS will be sent to the CHWs to promote contact with these women during home visits. Reserchers will use the Consolidated Framework for Implementation Research (CFIR) as an organizing and analytic framework to evaluate the implementation of the intervention while also drawing on Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM). Researchers will conduct a self-administered, semi-structured survey of CHWs, semi-structured interviews with local health authorities, and a survey of HPV+ women.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Women With Triage Pap Smears at 120 Days After HPV Results
314; 163
SECONDARY
Percentage of Women With Triage Pap Smears at 60 Days After HPV Results
242; 101

Eligibility Criteria

Inclusion Criteria

In the Randomized Controlled Trial we will recruit a minimum of 4000 women, aged 30 and older living in the province of Jujuy, Argentina.

Inclusion criteria are:

  • Having performed self-collection of HPV-testing.
  • Mentally competent to understand the consent form.
  • Able to communicate with study staff.
  • Being able to provide a mobile phone telephone number.

Exclusion Criteria

  • Current pregnancy.
  • Women with Mental disability.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03478397). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search